Press Releases

NORTH PALM BEACH, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that its Board of Directors has approved a consolidation of the Company's issued and outstanding common stock on a 60-to-1 basis (the "Share Consolidation"), to be effective July 6, 2026 (the "Effective Date"). On the Effective Date, every 60 shares of issued and outstanding common stock will be automatically combined into one share of common stock. The Company's common stock will continue to trade on the NYSE American under the existing symbol "SRXH" a

Oceaneering International, Inc. ("Oceaneering") (NYSE:OII) announced today that it has commenced a cash tender offer to purchase any and all of its outstanding 6.000% Senior Notes due 2028 (the "Notes") for the consideration described below. Title of Security CUSIP Numbers(2) Aggregate Principal Amount Outstanding U.S. Treasury Reference Security Bloomberg Reference Page Fixed Spread (basis points) 6.000% Senior Notes due 2028(1) 675232 AB8 675232 AD4   $500,000,000 3.50% UST due October 31, 2027 FIT4 40 _______________ (1) In addition to the consideration per $1,000 set forth above per p

Oceaneering International, Inc. ("Oceaneering") (NYSE:OII) announced today that it intends to offer $500,000,000 aggregate principal amount of Senior Notes due 2034 (the "2034 Notes") in a private placement to eligible purchasers. Oceaneering intends to use the net proceeds from the proposed offering, together with cash on hand, if necessary, to fund the purchase of any and all of its 6.000% Senior Notes due 2028 (the "Tender Notes") validly tendered and accepted for purchase in the concurrent cash tender offer announced today (the "Tender Offer"). If the Tender Offer is not consummated or the net proceeds from the offering exceed the total consideration payable in the Tender Offer, Ocean

Brera Holdings PLC (d/b/a Solmate Infrastructure) issues the following statement regarding RBCH derivative lawsuit: We are currently engaged in a critical effort to protect the Company and its shareholders from what we believe is a fraudulent campaign by the RockawayX Managing Partner and CEO, Viktor Fischer, aimed at exploiting the Company and its assets for personal gain. What began as an attempt to extract approximately $200 million from the Company, as described in the Company’s lawsuit against Mr Fischer and his company RX, has evolved into a broader false attack that has negatively impacted market perception and contributed to a significant discount in the Company’s valuation. Mr

Planned ~17% workforce reduction expected to generate annualized estimated savings of approximately $10M, enhancing financial flexibility Company focused on delivering upcoming regulatory and clinical milestones, including planned LOTIS-5 sBLA submission and full LOTIS-7 data by end of 2026LAUSANNE, Switzerland, June 24, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE:ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced a strategic reorganization to focus resources behind key value-driving initiatives in support of the ZYNLONTA® (loncastuximab tesirine-lpyl) franchise.

TORONTO, June 24, 2026 /CNW/ - CIBC has been named the Best Overall Cash Management Bank in Canada for 2026 by Global Finance. This recognition underscores the bank's ongoing commitment to delivering innovative, client-focused solutions to commercial clients across the country. Global Finance's Treasury & Cash Management awards recognize financial institutions driven by digital advancements and innovative solutions.  "Our tailored, digital-first solutions help companies manage cash flow, finance growth, improve efficiency, and reduce risk, while our team ensures every client receives advice and execution aligned with their indu

Dedicated Kalshi pricing now live on Tradeweb for U.S. institutional clients Kalshi’s American Power Index (KPOW) coming to Tradeweb in July Tradeweb Markets Inc. (NASDAQ:TW), a global leader in electronic trading across asset classes, today announced the launch of a dedicated Kalshi pricing page on the Tradeweb platform, giving U.S. institutional clients access to key event contract data alongside the existing tools and information they use to analyze markets and manage risk. The launch marks the first phase of Tradeweb’s previously announced strategic partnership with Kalshi and comes as investors increasingly seek additional sources of information to navigate market volatility, geo

Record net sales for fiscal 2026 of $838.7 millionRecord orders for fiscal 2026 of $860.8 millionQ4 EPS of $0.17, adjusted EPS(1) of $0.27, up 50% from adjusted EPS(1) YoYProduct backlog rose to $356.2 million at year end with solid pipeline entering fiscal 2027 BROOKINGS, S.D., June 24, 2026 (GLOBE NEWSWIRE) -- Daktronics, Inc. (NASDAQ:DAKT) (the "Company", "Daktronics", "we", "our", or "us"), a recognized industry leader in the design and manufacturing of best-in-class dynamic video communication displays and control systems for customers worldwide, today reported results for its fiscal year and fourth quarter ended May 2, 2026. Fiscal 2026 was a 53-week year, with an extra week

The Real Brokerage Inc. (NASDAQ:REAX), a leading real estate technology platform redefining the industry through innovation and culture, today announced it has surpassed 35,000 agents across the United States and Canada. The milestone comes as the company marks 12 years of helping agents build thriving businesses through industry-leading technology, a collaborative professional community and a culture centered on agent success. Twelve years after its founding, Real ranks among the five largest brokerages in the United States based on agent count and sales volume, according to the 2025 RealTrends Verified Brokerage Rankings. It added more than 3,200 agents in the first half of 2026 alone,

- Zervimesine Would be the First Long-term, Durable Treatment Option with an Impact on Underlying Disease -- Company Developing NPI as a Measure of DLB Psychosis - PURCHASE, N.Y., June 24, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the "Company" or "Cognition") (NASDAQ:CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders, today announced that it received written feedback from the U.S. Food and Drug Administration (FDA) following its recent meeting. The FDA agreed that psychosis associated with dementia with Lewy bodies (DLB) could be an approvable outcome and reached alignment with the Company on key aspects of a pivotal trial t

Hertz Global Holdings, Inc. (NASDAQ:HTZ) ("Hertz" or the "Company"), a leading global rental car company, today announced that it intends to offer shares of its common stock, par value $0.01 per share, (the "Common Stock") at an aggregate public offering price of $100 million in a SEC-registered offering. Such shares (the "Borrowed Shares") will be loaned by the Company to J.P. Morgan Securities LLC (in such capacity, the "Share Borrower"), one of the underwriters of the offering of the Borrowed Shares, pursuant to a share lending agreement. The Share Borrower or its affiliates will receive all of the proceeds of the offering of Borrowed Shares and neither the Company nor The Hertz Corporat

Hertz Global Holdings, Inc. (NASDAQ:HTZ) ("Hertz" or the "Company"), a leading global rental car company, today announced that its wholly-owned indirect subsidiary, The Hertz Corporation ("Hertz Corp."), intends to offer, subject to market and other conditions, $300 million in aggregate principal amount of Exchangeable Senior First-Lien Secured PIK Notes due 2030 (the "Notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Hertz Corp. also expects to grant the initial purchasers of the Notes an option to purchase, for settlement within a period of 13 days fro

IRVINE, Calif., June 24, 2026 /PRNewswire/ -- The global electric vehicle revolution has entered a new phase. For years, the EV conversation centered on range, charging speed and performance. Today, as electric vehicles move from early adopters into the mainstream, a different question is shaping consumer decisions: Who can drivers trust for the long haul? The numbers tell the story. According to the International Energy Agency (IEA), one in four new cars sold worldwide in 2025 was electric. Global EV sales surpassed 20 million units, marking the fifth consecutive year of record growth. Electric vehicles now account for approxi

Single ascending dose study evaluating safety, tolerability, and pharmacokinetics of VK3019Potential to further expand Viking's treatment options for weight lossSAN DIEGO, June 24, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today the initiation of a Phase 1 single ascending dose (SAD) clinical trial of VK3019, an investigational dual amylin and calcitonin receptor agonist (DACRA). VK3019 is being developed as a potential treatment option for weight loss. The study initiation follows the filing and clearance of VK3019's investi

Generates $11.6 Million Realized Gain from Exit of Equity Investment in Centre Technologies Holdings, LLCHOUSTON, June 24, 2026 /PRNewswire/ -- MSC Income Fund, Inc. (NYSE:MSIF) ("MSC Income" or the "Fund") is pleased to announce that it recently exited its debt investments and equity investment in Centre Technologies Holdings, LLC ("Centre" or the "Company") upon the completion of a majority recapitalization with a new financial sponsor. Founded in 2006 and headquartered in Houston, Texas, Centre is a provider of information technology (IT) services, including managed services, cloud solutions, cyber security, IT consulting and business intelligence (BI) services to lower and middle market

Confirmatory study completed ahead of schedule due to strong patient demand and robust investigator interestOn track to initiate BLA in Q3 2026 under the accelerated approval pathway supporting potential approval in 2H 2027ROCKVILLE, Md., June 24, 2026 /PRNewswire/ -- REGENXBIO Inc. (NASDAQ:RGNX) today announced the successful completion of dosing in the confirmatory study of RGX-202, a potential best-in-class gene therapy for Duchenne muscular dystrophy. This milestone positions REGENXBIO to initiate a Biologics License Application (BLA) under the accelerated approval pathway in Q3 2026 for a potential approval by the U.S. Food and Drug Administration (FDA) in the second half of 2027.The BL

$272 Million in Premium Asset Sales and GrowingVenu Holding Corporation ("VENU" or the "Company") (NYSE:VENU), an owner, operator, and developer of premium live entertainment destinations, today announced that it hosted a private investor event just north of Dallas, in McKinney, Texas, featuring NFL Hall of Famer, three-time Super Bowl Champion, national spokesperson, and VENU® shareholder Troy Aikman.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260624144272/en/VENU Hosts Intimate FireSuite Investor Event in McKinney, Texas Featuring Three-Time Super Bowl Champion and VENU Shareholder Troy AikmanThe event took place this past Mo

WARSAW, Ind., June 24, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced an exclusive distribution agreement with OSSIO, Inc. ("OSSIO") that brings U.S. children’s hospitals nationwide a bio-integrative, metal-free fixation technology ideally suited for treatment of fractures and deformities in pediatric patients. After performing their fixation function, OSSIOfiber® implants are gradually replaced by the patient’s newly formed bone during the natural healing process. This technological advance in material science decreases the need for hardware r

Will deliver its LVSS vehicle-based platform for the Enhanced Mobile Surveillance Capability-Lite program to secure U.S. borders Teledyne Technologies Incorporated (NYSE:TDY) announced that Teledyne FLIR Defense has won a $28.8 million contract from U.S. Customs and Border Protection (CBP), an agency of the U.S. Department of Homeland Security, to support the agency’s Enhanced Mobile Surveillance Capability–Lite (eMSC-L) program to bolster border security operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260624478803/en/Teledyne FLIR Defense has won a $28.8 million contract from U.S. Customs and Border Protection, an

Proceeds expected to support a focused pulmonary hypertension strategy, including a Phase 1b proof-of-concept study evaluating Auxora™ in PAH, with data anticipated mid-2027, and advancement of oral CRAC channel inhibitor CM5480 to IND clearance expected mid-2027Anticipated cash runway into 2H 2027 with upfront proceedsLA JOLLA, Calif., June 24, 2026 /PRNewswire/ -- CalciMedica, Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and cardiopulmonary diseases, today announced it has entered into a definitive securities purcha